Radiation blast may supercharge cancer drugs in small trial
NCT ID NCT03610711
Summary
This study is testing if giving targeted, high-dose radiation to cancer spots before starting immunotherapy drugs makes the drugs work better for people with advanced stomach or esophageal cancer. It's a small, early-stage safety trial for patients whose cancer has spread but is still limited. Researchers will check if the radiation changes the immune cells in a tumor and see how safe the combination is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alleghany Health Network
Pittsburgh, Pennsylvania, 15212, United States
-
Baylor University
Dallas, Texas, 75246, United States
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.